HomeInsights52 Week High Stocks

Glenmark Pharmaceuticals Ltd 52 Week High

Glenmark Pharmaceuticals Ltd 52 Week High

stocks purchased

₹ 1.1 Cr

Volume Transacted

(Dec 26, 2024)

stocks purchased

6.9 K

Stocks Traded

(Dec 26, 2024)

Last Updated on: Dec 26, 2024

Image

Glenmark Pharmaceuticals Ltd

NSE: GLENMARK

YEARHIGH

₹ 1830.05

Last updated on: Dec 24, 2024

Key Highlights

  • The 52 Week HIGH of Glenmark Pharmaceuticals Ltd is ₹ 1830 as of 24 Dec 24 .

Company Fundamentals for Glenmark Pharmaceuticals Ltd

No data available

Market Price of Glenmark Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Glenmark Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
24 Dec 20241536.15
23 Dec 20241549.95
20 Dec 20241542.35
19 Dec 20241540
18 Dec 20241524.2
17 Dec 20241512.6
16 Dec 20241551.4
13 Dec 20241517.2
12 Dec 20241534.5
11 Dec 20241526.1

Asset Value vs Market Value of Glenmark Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Glenmark Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Glenmark Pharmaceuticals Ltd

No data available

* All values are in crore

Glenmark Pharmaceuticals Ltd News Hub

News

Glenmark Pharmaceuticals Inc. USA launches Lacosamide Oral Solution

Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch of Lacosamide Oral Solu...

Read more

16 Dec 2024 09:06

News

Glenmark Pharma arm launches seizure drug in US

The newly launched drug is bioequivalent and therapeutically equivalent to the reference l...

Read more

16 Dec 2024 09:41

News

Glenmark Pharmaceuticals Ltd up for third straight session

Glenmark Pharmaceuticals Ltd is up for a third straight session today. The stock is quotin...

Read more

03 Dec 2024 13:06

News

Glenmark Pharma launches Travoprost Ophthalmic Solution USP

Glenmark Pharmaceuticals Inc., USA (Glenmark) announced the launch of Travoprost Ophthalmi...

Read more

27 Nov 2024 09:12

News

Glenmark Pharma arm launches Travoprost Ophthalmic Solution in U.S market

Travoprost ophthalmic is used to treat glaucoma (a condition in which increased pressure i...

Read more

27 Nov 2024 09:59

News

Glenmark Pharmaceuticals Ltd eases for fifth straight session

Glenmark Pharmaceuticals Ltd dropped for a fifth straight session today. The stock is quot...

Read more

18 Nov 2024 13:35

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of Glenmark Pharmaceuticals Ltd

What is the significance of Glenmark Pharmaceuticals Ltd reaching its 52-week high?

Glenmark Pharmaceuticals Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Glenmark Pharmaceuticals Ltd 52-week high?

Investors monitor Glenmark Pharmaceuticals Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Glenmark Pharmaceuticals Ltd a good buy when it hits its 52-week high?

Whether Glenmark Pharmaceuticals Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Glenmark Pharmaceuticals Ltd fundamentals.

What should I consider before investing in Glenmark Pharmaceuticals Ltd at its 52-week high?

Before investing in Glenmark Pharmaceuticals Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Glenmark Pharmaceuticals Ltd stock price continue to rise after reaching its 52-week high?

Glenmark Pharmaceuticals Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions